Catalent enters agreement to sell its U.S. commercial packaging operations
Posted: 31 May 2012 | | No comments yet
Catalent signed a definitive agreement to sell its U.S. commercial packaging operations based in Philadelphia, PA and Woodstock, IL…
Catalent Pharma Solutions recently signed a definitive agreement to sell its U.S. commercial packaging operations based in Philadelphia, PA and Woodstock, IL to a company affiliated with Frazier Healthcare. The transaction is subject to certain closing conditions and is expected to close in the next few months.The transaction does not involve Catalent’s Clinical Supply Services operations in Philadelphia, or the Blow-Fill-Seal business in Woodstock. It also does not involve any commercial packaging activity that Catalent conducts outside North America.
Catalent’s decision to sell its U.S. commercial packaging operations is based on the company’s business strategy to focus on growing its world leading businesses in development solutions and advanced delivery technologies, clinical trial supplies, advanced blow/fill/seal aseptic delivery technology for respiratory, ophthalmic and other products, as well as offering integrated solutions for the development and supply of injectable biologics and complex pharmaceutical products.
Frazier Healthcare was founded in 1991 to invest exclusively in healthcare, and is a leading provider of growth equity and venture capital to high growth and emerging healthcare companies.